A regulated market with a defined buyer pool, where location approval is part of the asset.
A pharmacy valuation in Sydney leads with the market approach, because ownership and location rules create a defined pool of buyers and an observable transaction market. Value is expressed as a multiple of maintainable earnings and tested against script volume, the PBS and non-PBS revenue mix and the lease.
Pharmacies are valued on a sale or purchase, admitting or retiring a partner, a family law property settlement, succession to an employed pharmacist, finance, and where the ATO requires a market value on a restructure.
Because only registered pharmacists may own a pharmacy in New South Wales, the buyer pool is narrow and well-informed. A seller without an independent valuation is usually negotiating against someone who has bought before and knows the metrics better than they do.
The Market Approach leads. Ownership and location rules produce a defined market with regular, observable transactions, so comparable sales are the strongest evidence available.
The guideline transaction method leads. Comparable pharmacy sales are narrowed by location type, whether a shopping centre, strip, medical centre or supermarket-anchored site, then by script volume, revenue mix, trading hours and lease terms, and expressed as a multiple of maintainable earnings.
The income approach is the main cross-check and it carries real weight where the pharmacy has a stable script base. Earnings are capitalised after the owner-pharmacist is paid a market salary for the professional hours actually worked, which is the adjustment that most often changes the answer.
Maintainable earnings capitalised after the owner-pharmacist is replaced at a market professional rate. This exposes pharmacies where the reported profit is largely the owner's own wage.
Inventory at realisable value with slow-moving and expiring stock written down, plus fit-out, dispensing robotics and equipment at market value. Stock is a substantial number in a pharmacy and it is rarely worth its cost.
Normalisation is the most common source of disagreement in a valuation, so it is set out in full in the report rather than buried in a schedule. For this industry the recurring adjustments are:
Pharmacies sit inside health care and retail at once, and the two divisions moved very differently in 2025 to 2026: health care and social assistance grew 6.7 per cent nationally to 227,702 businesses while retail trade was effectively flat at 0.1 per cent (Source: ABS, Counts of Australian Businesses, July 2022 to June 2026, released 18 August 2026). A pharmacy's revenue mix determines which of those conditions it is actually exposed to.
Ownership and approval are part of the asset in a way that is unusual for a retail business. Only registered pharmacists may own a pharmacy in New South Wales, and dispensing under the Pharmaceutical Benefits Scheme requires approval as a PBS supplier (Source: Department of Health, Disability and Ageing, PBS approved suppliers). That regulation both narrows the buyer pool and supports value, because it limits how quickly a competitor can open nearby.
Site type drives the comparable set in Sydney far more than suburb does. A medical-centre pharmacy with captive referral flow, a supermarket-anchored shopping centre pharmacy on a percentage rent, and a strip pharmacy serving an established residential catchment have different scripts per hour, different rent structures and different risk, and they should not be compared to one another.
Still being sourced before publication: [VERIFY: Number of PBS approved community pharmacies in New South Wales, from the Department of Health, Disability and Ageing PBS approved suppliers data]; [VERIFY: Median earnings multiple for Greater Sydney pharmacy sales over the last 24 months].
The report states the purpose of the valuation, the standard of value applied, the valuation date, the information relied on and its limitations. It sets out each approach considered, the method chosen under each, the normalisation adjustments made and the reason for each one, then reconciles the results into a range and explains the weighting in words rather than by formula.
That reconciliation narrative is a large part of what makes an opinion defensible. A conclusion that cannot explain why one approach was preferred over another, or why a particular point in a multiple range was selected, is difficult to sustain when another expert reviews it. Reports are prepared consistently with APESB, APES 225 Valuation Services and are signed by a credentialed certified valuer who is prepared to explain and defend the opinion.
If another expert reviewed this report, which assumption would they challenge first, and what is your answer? A valuer who cannot answer that has not finished the work.
An Indicative valuation suits an owner testing whether to sell or an employed pharmacist testing what they could fund. It is for internal decision-making and is not written for third party reliance. A Summary report suits a sale, a partner admission or a finance application. A Detailed report is required for family law, partner disputes and anything subject to expert review.
Purpose drives the choice. The more likely it is that the opinion will be reviewed by another expert, a court, a lender or the ATO, the deeper the report needs to be.
For internal decision-making. Useful for testing an offer, setting an expectation before a negotiation, or deciding whether to go to market. It is not written for third party reliance.
Sets out the approaches applied, the normalisation adjustments made and the reasoning behind the conclusion. The usual choice for a sale, an ownership change or a finance application.
Applies and reconciles all relevant approaches in full. The level required where a court, the ATO, a lender or another expert will review the opinion.